(ACN) Accenture - Ratings and Ratios

Exchange: NYSE • Country: Ireland • Currency: USD • Type: Common Stock • ISIN: IE00B4BNMY34

Consulting, Technology, Operations, Software, Data, AI, Automation

ACN EPS (Earnings per Share)

EPS (Earnings per Share) of ACN over the last years for every Quarter: "2020-02": 1.91, "2020-05": 1.9, "2020-08": 1.99, "2020-11": 2.32, "2021-02": 2.23, "2021-05": 2.4, "2021-08": 2.2, "2021-11": 2.78, "2022-02": 2.54, "2022-05": 2.79, "2022-08": 2.6, "2022-11": 3.08, "2023-02": 2.39, "2023-05": 3.15, "2023-08": 2.15, "2023-11": 3.1, "2024-02": 2.63, "2024-05": 3.04, "2024-08": 2.66, "2024-11": 3.59, "2025-02": 2.82, "2025-05": 3.49,

ACN Revenue

Revenue of ACN over the last years for every Quarter: 2020-02: 11141.505, 2020-05: 10991.305, 2020-08: 10835.271, 2020-11: 11762.185, 2021-02: 12088.125, 2021-05: 13263.795, 2021-08: 13419.284, 2021-11: 14965.153, 2022-02: 15046.693, 2022-05: 16158.803, 2022-08: 15423.656, 2022-11: 15747.802, 2023-02: 15814.158, 2023-05: 16564.585, 2023-08: 15985.2, 2023-11: 16224.303, 2024-02: 15799.514, 2024-05: 16466.828, 2024-08: 16405.819, 2024-11: 17689.545, 2025-02: 16659.301, 2025-05: 17727.871,

Description: ACN Accenture

Accenture plc is a global professional services company that provides a broad range of services, including strategy and consulting, digital transformation, and technology services, to clients across various industries, such as communications, media, and technology, banking, and healthcare. The companys diverse service offerings enable it to help clients navigate complex business challenges and capitalize on emerging opportunities.

From a business perspective, Accentures operations can be evaluated using key performance indicators (KPIs) such as revenue growth, operating margin, and new bookings. The companys ability to expand its services into emerging areas like artificial intelligence, cloud computing, and cybersecurity is a key driver of its growth. Additionally, Accentures collaboration with academic institutions, such as Kyoto University, to advance research and innovation in areas like human-centered AI, is a strategic move to stay ahead of the curve.

To assess Accentures financial health, we can examine metrics such as return on equity (RoE), which is currently at 27.11%, indicating a strong ability to generate profits from shareholder equity. Other relevant KPIs include revenue per employee, client satisfaction, and employee utilization rates, which can provide insights into the companys operational efficiency and competitiveness.

From an industry perspective, Accenture operates in the IT consulting and services space, which is characterized by high demand for digital transformation and technology-enabled services. The companys diversified industry coverage and strong brand reputation position it well to capitalize on these trends. To further evaluate Accentures prospects, we can analyze its competitive positioning, market share, and growth prospects relative to its peers in the industry.

ACN Stock Overview

Market Cap in USD 153,321m
Sub-Industry IT Consulting & Other Services
IPO / Inception 2001-07-19

ACN Stock Ratings

Growth Rating -14.9%
Fundamental 83.7%
Dividend Rating 66.7%
Return 12m vs S&P 500 -34.3%
Analyst Rating 4.15 of 5

ACN Dividends

Dividend Yield 12m 2.01%
Yield on Cost 5y 2.66%
Annual Growth 5y 10.28%
Payout Consistency 98.9%
Payout Ratio 47.1%

ACN Growth Ratios

Growth Correlation 3m -91.8%
Growth Correlation 12m -75.2%
Growth Correlation 5y 50.9%
CAGR 5y 2.88%
CAGR/Max DD 5y 0.07
Sharpe Ratio 12m -0.43
Alpha -34.44
Beta 0.538
Volatility 28.21%
Current Volume 2982.8k
Average Volume 20d 4675k
Stop Loss 248.4 (-3%)
Signal -1.21

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (7.95b TTM) > 0 and > 6% of Revenue (6% = 4.11b TTM)
FCFTA 0.16 (>2.0%) and ΔFCFTA 0.16pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 12.63% (prev 4.45%; Δ 8.18pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.17 (>3.0%) and CFO 10.95b > Net Income 7.95b (YES >=105%, WARN >=100%)
Net Debt (-3.76b) to EBITDA (11.89b) ratio: -0.32 <= 3.0 (WARN <= 3.5)
Current Ratio 1.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (630.5m) change vs 12m ago -0.81% (target <= -2.0% for YES)
Gross Margin 32.07% (prev 32.60%; Δ -0.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 116.6% (prev 119.1%; Δ -2.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 57.86 (EBITDA TTM 11.89b / Interest Expense TTM 185.1m) >= 6 (WARN >= 3)

Altman Z'' 3.84

(A) 0.14 = (Total Current Assets 27.42b - Total Current Liabilities 18.77b) / Total Assets 63.36b
(B) 0.42 = Retained Earnings (Balance) 26.45b / Total Assets 63.36b
(C) 0.18 = EBIT TTM 10.71b / Avg Total Assets 58.75b
(D) 0.34 = Book Value of Equity 10.97b / Total Liabilities 31.81b
Total Rating: 3.84 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 83.70

1. Piotroski 5.0pt = 0.0
2. FCF Yield 6.85% = 3.42
3. FCF Margin 14.96% = 3.74
4. Debt/Equity 0.19 = 2.48
5. Debt/Ebitda 0.49 = 2.31
6. ROIC - WACC 16.77% = 12.50
7. RoE 27.11% = 2.26
8. Rev. Trend 81.88% = 4.09
9. Rev. CAGR 5.19% = 0.65
10. EPS Trend 44.37% = 1.11
11. EPS CAGR 11.30% = 1.13

What is the price of ACN shares?

As of August 29, 2025, the stock is trading at USD 256.17 with a total of 2,982,834 shares traded.
Over the past week, the price has changed by +0.86%, over one month by -7.53%, over three months by -18.53% and over the past year by -22.68%.

Is Accenture a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, Accenture (NYSE:ACN) is currently (August 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 83.70 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACN is around 212.55 USD . This means that ACN is currently overvalued and has a potential downside of -17.03%.

Is ACN a buy, sell or hold?

Accenture has received a consensus analysts rating of 4.15. Therefore, it is recommended to buy ACN.
  • Strong Buy: 12
  • Buy: 6
  • Hold: 8
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ACN price?

Issuer Target Up/Down from current
Wallstreet Target Price 326.7 27.5%
Analysts Target Price 356.3 39.1%
ValueRay Target Price 235.4 -8.1%

Last update: 2025-08-15 15:19

ACN Fundamental Data Overview

Market Cap USD = 153.32b (153.32b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 9.63b USD (last quarter)
P/E Trailing = 19.5676
P/E Forward = 17.4216
P/S = 2.2388
P/B = 5.0081
P/EG = 1.8938
Beta = 1.29
Revenue TTM = 68.48b USD
EBIT TTM = 10.71b USD
EBITDA TTM = 11.89b USD
Long Term Debt = 5.04b USD (from longTermDebt, last quarter)
Short Term Debt = 839.3m USD (from shortTermDebt, last quarter)
Debt = 5.88b USD (Calculated: Short Term 839.3m + Long Term 5.04b)
Net Debt = -3.76b USD (from netDebt column, last quarter)
Enterprise Value = 149.57b USD (153.32b + Debt 5.88b - CCE 9.63b)
Interest Coverage Ratio = 57.86 (Ebit TTM 10.71b / Interest Expense TTM 185.1m)
FCF Yield = 6.85% (FCF TTM 10.24b / Enterprise Value 149.57b)
FCF Margin = 14.96% (FCF TTM 10.24b / Revenue TTM 68.48b)
Net Margin = 11.61% (Net Income TTM 7.95b / Revenue TTM 68.48b)
Gross Margin = 32.07% ((Revenue TTM 68.48b - Cost of Revenue TTM 46.52b) / Revenue TTM)
Tobins Q-Ratio = 13.64 (Enterprise Value 149.57b / Book Value Of Equity 10.97b)
Interest Expense / Debt = 1.15% (Interest Expense 67.6m / Debt 5.88b)
Taxrate = 23.51% (from yearly Income Tax Expense: 2.28b / 9.70b)
NOPAT = 8.19b (EBIT 10.71b * (1 - 23.51%))
Current Ratio = 1.46 (Total Current Assets 27.42b / Total Current Liabilities 18.77b)
Debt / Equity = 0.19 (Debt 5.88b / last Quarter total Stockholder Equity 30.55b)
Debt / EBITDA = 0.49 (Net Debt -3.76b / EBITDA 11.89b)
Debt / FCF = 0.57 (Debt 5.88b / FCF TTM 10.24b)
Total Stockholder Equity = 29.32b (last 4 quarters mean)
RoA = 12.55% (Net Income 7.95b, Total Assets 63.36b )
RoE = 27.11% (Net Income TTM 7.95b / Total Stockholder Equity 29.32b)
RoCE = 31.18% (Ebit 10.71b / (Equity 29.32b + L.T.Debt 5.04b))
RoIC = 24.50% (NOPAT 8.19b / Invested Capital 33.44b)
WACC = 7.74% (E(153.32b)/V(159.20b) * Re(8.0%)) + (D(5.88b)/V(159.20b) * Rd(1.15%) * (1-Tc(0.24)))
Shares Correlation 5-Years: -100.0 | Cagr: -0.57%
Discount Rate = 8.0% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 78.78% ; FCFE base≈9.61b ; Y1≈9.94b ; Y5≈11.29b
Fair Price DCF = 318.6 (DCF Value 198.46b / Shares Outstanding 622.9m; 5y FCF grow 3.53% → 3.0% )
Revenue Correlation: 81.88 | Revenue CAGR: 5.19%
Rev Growth-of-Growth: 3.22
EPS Correlation: 44.37 | EPS CAGR: 11.30%
EPS Growth-of-Growth: 14.32

Additional Sources for ACN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle